Update Type: Replacement Test
Test Updated: 08/11/2021
Test Overview
Test Methodology
LC-MS/MS
Test Usage
Paliperidone (9-hydroxyrisperidone) is the active ingredient in Invega extended-release tablets. Paliperidone is also the major active metabolite of Risperidone. Steady-state concentrations are typically attained within 4 to 5 days of dosing. Following daily administration of 12 mg extended release formulation, paliperidone steady state plasma concentrations ranged from 30 to 40 ng/mL.
Reference Range *
Reporting limit determined each analysis
Test Details
Days Set Up
Monday - Sunday
Analytic Time
8 - 12 days
Soft Order Code
FPALI
MiChart Code
FPALI
Laboratory
Sendout
Reference Laboratory
Mayo FPALI (NMS Labs)
Section
Special Testing
Specimen Requirements
Collection
Red top only, no SST
Collection Instructions
Collect specimen in a red top tube (NO SST). Spin and aliquot into a plastic, screw capped tube. Send to Specimen Processing refrigerated
Normal Volume
1 mL serum
Minimum Volume
0.5 mL serum
Storage Temperature
Ambient is also acceptable
Rejection Criteria
Specimen collected in anything but a red top tube
Additional Information
Test sent to Mayo Clinic Labs; performed by NMS labs
Billing
CPT Code
80342
Fee Code
AA588
NY State Approved
No